iBio IBIO
NASDAQ IBIO
$1.25 -0.01 (-0.79%)
As of: Sep 10, 2026 · 9:55 AM EDT

iBio (IBIO) Work In Process (2016 - 2022)

iBio's (IBIO) quarterly Work In Process came in at $4000.0 in Q2 2022, down 85.19% year-over-year from $27000.0 in Q2 2021, and down 87.1% quarter-over-quarter from $31000.0 in Q4 2021.

Analysis

iBio (IBIO) Work In Process (2016 - 2022) Analysis & Trends

iBio (IBIO) has reported Work In Process for 5 consecutive years, with $4000.0 the latest figure, recorded in Q2 2022.

  • On a quarterly basis, Work In Process fell 85.19% year-over-year to $4000.0 in Q2 2022; TTM through Jun 2022 was $4000.0, a 85.19% decrease from a year earlier, with the FY2022 full-year figure at $4000.0, down 85.19% from the prior year.
  • Work In Process was $4000.0 for Q2 2022 at iBio, down from $31000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $1.1 million in Q4 2020 and troughed at $4000.0 in Q2 2022.
  • A 3-year average of $407875.0 and a median of $244500.0 in 2021 frame the typical range for Work In Process.
  • Across the five-year window, Work In Process tumbled 97.11% in 2021 and tumbled 85.19% in 2022, its largest moves.
  • Over 3 years, Work In Process stood at $1.1 million in 2020, then plunged by 97.11% to $31000.0 in 2021, then sank by 87.1% to $4000.0 in 2022.
  • The last three Work In Process figures came in at $4000.0 (Q2 2022), $31000.0 (Q4 2021), and $57000.0 (Q3 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 209.95 Bn 195.96 Bn 7.24 Bn
2 Gilead Sciences 180.35 Bn 177.17 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.26 Bn 124.41 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.62 Bn 74.62 Bn 3.93 Bn
5 Argenx Se 61.19 Bn 56.00 Bn 1.37 Bn
6 Moderna 53.61 Bn 48.47 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.75 Bn 30.44 Bn 992.69 Mn
8 Biogen 31.58 Bn 30.30 Bn 1.96 Bn
9 Roivant Sciences 29.42 Bn 29.42 Bn 1.16 Mn
10 iBio 131.12 Mn 131.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 4,000.00
Dec 31, 2021 31,000.00
Sep 30, 2021 57,000.00
Jun 30, 2021 27,000.00
Mar 31, 2021 432,000.00
Dec 31, 2020 1.07 Mn
Sep 30, 2020 843,000.00
Jun 30, 2020 798,000.00
Jun 30, 2017 26,000.00
Mar 31, 2017 60,000.00
Dec 31, 2016 27,000.00
Jun 30, 2016 22,000.00
Mar 31, 2016 58,000.00